Brown Advisory’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-84,989
| Closed | -$1.33M | – | 1248 |
|
|
2019
Q1 | $1.33M | Buy |
84,989
+35,061
| +70% | +$550K | ﹤0.01% | 738 |
|
|
2018
Q4 | $770K | Sell |
49,928
-729
| -1% | -$11.2K | ﹤0.01% | 813 |
|
|
2018
Q3 | $1.09M | Buy |
+50,657
| New | +$1.09M | ﹤0.01% | 797 |
|
|
2017
Q4 | – | Sell |
-75,712
| Closed | -$1.33M | – | 1253 |
|
|
2017
Q3 | $1.33M | Sell |
75,712
-3,005,966
| -98% | -$52.9M | ﹤0.01% | 602 |
|
|
2017
Q2 | $102M | Buy |
3,081,678
+514,280
| +20% | +$17.1M | 0.31% | 70 |
|
|
2017
Q1 | $82.4M | Sell |
2,567,398
-639,120
| -20% | -$20.5M | 0.28% | 78 |
|
|
2016
Q4 | $116M | Sell |
3,206,518
-253,986
| -7% | -$9.21M | 0.42% | 59 |
|
|
2016
Q3 | $159M | Sell |
3,460,504
-23,642
| -0.7% | -$1.09M | 0.55% | 49 |
|
|
2016
Q2 | $175M | Buy |
3,484,146
+363,968
| +12% | +$18.3M | 0.61% | 41 |
|
|
2016
Q1 | $167M | Sell |
3,120,178
-116,495
| -4% | -$6.23M | 0.58% | 43 |
|
|
2015
Q4 | $212M | Buy |
3,236,673
+140,802
| +5% | +$9.24M | 0.72% | 38 |
|
|
2015
Q3 | $175M | Buy |
3,095,871
+274,289
| +10% | +$15.5M | 0.62% | 41 |
|
|
2015
Q2 | $167M | Sell |
2,821,582
-14,186
| -0.5% | -$838K | 0.54% | 43 |
|
|
2015
Q1 | $177M | Sell |
2,835,768
-53,553
| -2% | -$3.34M | 0.56% | 41 |
|
|
2014
Q4 | $166M | Buy |
2,889,321
+25,825
| +0.9% | +$1.49M | 0.52% | 43 |
|
|
2014
Q3 | $154M | Buy |
2,863,496
+289,152
| +11% | +$15.5M | 0.49% | 44 |
|
|
2014
Q2 | $135M | Sell |
2,574,344
-22,748
| -0.9% | -$1.19M | 0.42% | 43 |
|
|
2014
Q1 | $137M | Buy |
2,597,092
+2,579,018
| +14,269% | +$136M | 0.44% | 40 |
|
|
2013
Q4 | $725K | Buy |
18,074
+2,350
| +15% | +$94.3K | ﹤0.01% | 569 |
|
|
2013
Q3 | $594K | Sell |
15,724
-1,040
| -6% | -$39.3K | ﹤0.01% | 592 |
|
|
2013
Q2 | $657K | Buy |
+16,764
| New | +$657K | ﹤0.01% | 542 |
|